Raymond Debbane
Director at Lexicon Pharmaceuticals, Inc. (LXRX)
Purchase track record
Strong record. Based on 3 purchases with a full 90 days of price history.
95
Avg. 90-day return+45.0%
vs. S&P 500+36.3%
Beat the market100%
Paper profit on buys+$151K
Total bought / sold$723K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 27SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 2,0001,906,186 held (+0%) | $1.49 | $3K | +12.8% |
| Feb 25SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 100,0001,904,186 held (+6%) | $1.47 | $147K | +14.3% |
| Feb 23SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 50,0001,704,186 held (+3%) | $1.44 | $72K | +16.7% |
| Feb 23SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 100,0001,804,186 held (+6%) | $1.48 | $148K | +13.5% |
| Feb 18SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 57,9521,443,641 held (+4%) | $1.31 | $76K | +28.2% |
| Feb 18SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 76,8571,520,498 held (+5%) | $1.31 | $101K | +28.2% |
| Feb 18SEC | LXRXLexicon Pharmaceuticals, Inc. | Buy | 133,6881,654,186 held (+9%) | $1.32 | $176K | +27.3% |
- Buy
Director Raymond Debbane bought $76K of LXRX at $1.31 — first open-market purchase in our records.
- Buy
Director Raymond Debbane bought $101K of LXRX at $1.31 — largest purchase by this insider in our records.
- Buy
Director Raymond Debbane bought $176K of LXRX at $1.32 — largest purchase by this insider in our records.